Combination Chemotherapy With or Without Anlotinib in the Maintenance Treatment of Non-Squamous Non-Small Cell Lung Cancer.

Condition:   Non-squamous Non-small-cell Lung Cancer Interventions:   Drug: Anlotinib + Pemetrexed+Carboplatin;   Drug: Pemetrexed;   Drug: Anlotinib + Pemetrexed;   Drug: Anlotinib Sponsor:   The First Affiliated Hospital with Nanjing Medical University Not yet recruiting

Source: ClinicalTrials.gov - July 1, 2020 Category: Research Source Type: clinical trials